» Articles » PMID: 4396080

Associations Between Drugs Administered During Pregnancy and Congenital Abnormalities of the Fetus

Overview
Journal Br Med J
Specialty General Medicine
Date 1971 Mar 6
PMID 4396080
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

In a retrospective study to compare the drug consumption during pregnancy of mothers of infants with congenital abnormalities and of those without, over 97% of 1,369 mothers took prescribed drugs and 65% self-administered drugs. Significantly more mothers of infants with congenital abnormalities took aspirin, antacids, dextroamphetamine, phenobarbitone, sodium amytal, other barbiturates, cough medicines, iron, sulphonamides, and nicotinamide than mothers in the control group. However, most mothers taking analgesics, antacids, appetite suppressants, barbiturates, cough medicines, iron, sulphonamides, and vitamins produced normal infants. Any teratogenic effect of these drugs is therefore one of low potency. On the other hand, deficiencies such as those of ascorbic acid and folic acid may have a teratogenic effect. There is need for caution in presuming teratogenic effects on the basis of the associations shown here. During pregnancy, however, it would appear wise to avoid the administration of any drug which carries a suspicion of teratogenicity unless that drug is specifically indicated, and self-medication with common household remedies such as aspirin and antacids should be avoided. These recommendations would also apply to any woman of childbearing age in whom conception is likely.

Citing Articles

Examining the Prevalence of Congenital Anomalies in Newborns: A Cross-Sectional Study at a Tertiary Care Maternity Hospital in Saudi Arabia.

Narapureddy B, Zahrani Y, Alqahtani H, Mugaiahgari B, Viswanath Reddy L, Asif S Children (Basel). 2024; 11(2).

PMID: 38397300 PMC: 10886957. DOI: 10.3390/children11020188.


Methamphetamine: burden, mechanism and impact on pregnancy, the fetus, and newborn.

Sankaran D, Lakshminrusimha S, Manja V J Perinatol. 2021; 42(3):293-299.

PMID: 34785765 DOI: 10.1038/s41372-021-01271-8.


Prevalence and associated factors of birth defects among newborns in sub-Saharan African countries: a systematic review and meta-analysis.

Adane F, Afework M, Seyoum G, Gebrie A Pan Afr Med J. 2020; 36:19.

PMID: 32774596 PMC: 7388615. DOI: 10.11604/pamj.2020.36.19.19411.


ADHD Medication Use During Pregnancy and Risk for Selected Birth Defects: National Birth Defects Prevention Study, 1998-2011.

Anderson K, Dutton A, Broussard C, Farr S, Lind J, Visser S J Atten Disord. 2018; 24(3):479-489.

PMID: 29519207 PMC: 6119527. DOI: 10.1177/1087054718759753.


Maternal Use of Weight Loss Products and the Risk of Neural Tube Defects in Offspring: A Systematic Literature Review.

Hoang T, Agopian A, Mitchell L Birth Defects Res. 2017; 110(1):48-55.

PMID: 29024488 PMC: 8919237. DOI: 10.1002/bdr2.1116.


References
1.
Crombie D, Pinsent R, SLATER B, Fleming D, Cross K . Teratogenic drugs--R.C.G.P. survey. Br Med J. 1970; 4(5728):178-9. PMC: 1819922. DOI: 10.1136/bmj.4.5728.178-c. View

2.
MACKLER B . Studies of the molecular basis of congenital malformations. Pediatrics. 1969; 43(6):915-26. View

3.
Nishimura H, Takano K, Tanimura T, Yasuda M, Uchida T . High incidence of several malformations in the early human embryos as compared with infants. Biol Neonat. 1966; 10(1):93-107. DOI: 10.1159/000240012. View

4.
Tattersall R . BARBITURATE TOXICITY. Practitioner. 1965; 194:68-71. View

5.
Nelson M, Forfar J . Congenital abnormalities at birth: their association in the same patient. Dev Med Child Neurol. 1969; 11(1):3-16. DOI: 10.1111/j.1469-8749.1969.tb01391.x. View